... led to the approval of the chemotherapeutic drug docetaxel for the treatment of metastatic prostate cancer in 2004. The researchers identified four independent risk factors that predicted whether a ...
... of grades 7, 8, 9 and 10 cancers," Dr. Kaplan explains.
This was worrying, since it is higher-grade, potentially metastatic prostate cancers that are the real cause for clinical concern. ...
For the past 70 years the treatment of choice for advanced, metastatic prostate cancer has been androgen-deprivation therapy. That is, the suppression of circulating testosterone - the hormone that ...
... Pathology.
According to Dr. Nevalainen, previous studies have shown that Stat3 is very active in metastatic prostate cancer, and the protein has been linked to cancer metastasis in several different ...
... is prostate cancer that has spread to a second site (something known as metastatic prostate cancer). Defining the molecular mechanisms by which the initial tumor becomes able to spread to a new site ...
... at The Institute of Cancer Research will pave the way for a test to be used to better tailor treatments and hopefully extend the survival of men with aggressive forms of metastatic prostate cancer.
... world. It is currently the second most common cause of cancer-related deaths among American men ... currently available for locally advanced or metastatic prostate cancer.
The median survival time of MV ...
... 262 samples of tissue, blood or urine associated with benign prostate tissue, early stage ... acid, were elevated in 79 percent of the metastatic prostate cancer samples and in 42 percent of the early ...
... has since moved to Memorial Sloan-Kettering Cancer Center in New York, where he ... on survival in a large group of patients with metastatic prostate cancer.
MDV3100 and RD162 are second-generation ...
... therapy is the standard treatment for men with locally advanced, recurrent and metastatic prostate cancer; but many active men who have been successfully treated for their cancer develop debilitating ...
... risky than others. Researchers told Europe's biggest cancer congress, ECCO 15 – ESMO 34 [1 ... Swedish men with locally advanced or metastatic prostate cancer who had received hormone therapy as primary ...
... don't know how many of them have missed cancer," says Dr. Sreekumar who joined the MCG faculty ... total of 89 metabolites were different in metastatic prostate cancer compared to localized disease.
He ...
... studies, elevated CRP was associated with poor survival in patients with metastatic prostate cancer as well as those with gastroesophogeal, colorectal, inoperable small-cell lung and pancreatic ...
... the-jci.org/article.php?id=34538
ONCOLOGY: New way to predict prostate cancer ... second site (something known as metastatic prostate cancer). Defining the molecular mechanisms by which the initial ...
... routinely used to diagnose prostate cancer whose levels increase in the blood of patients with metastatic prostate cancer.
Previous research hinted that FRAP and PAP may have a shared identity. To ...
